XIILAB CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,920 KRW | -0.20% |
|
-0.60% | -5.25% |
| Mar. 18 | Xiilab Unveils Cutting-Edge AI Technologies At NVIDIA GTC | CI |
| 2022 | XIIlab Co.,Ltd(KOSDAQ:A189330) dropped from S&P Global BMI Index | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 193,777 | 80,766 | 63,786 |
| Enterprise Value (EV) 1 | 171,702 | 64,031 | 52,295 |
| P/E ratio | -87.4 x | -17.8 x | -9.85 x |
| Yield | - | - | - |
| Capitalization / Revenue | 33.5 x | 8.16 x | 17.4 x |
| EV / Revenue | 29.7 x | 6.47 x | 14.3 x |
| EV / EBITDA | -144 x | -17.1 x | -9.17 x |
| EV / FCF | - | -15,778,760 x | -15,581,804 x |
| FCF Yield | - | -0% | -0% |
| Price to Book | 7.9 x | 3.9 x | 4.31 x |
| Nbr of stocks (in thousands) | 6,027 | 6,027 | 6,092 |
| Reference price 2 | 32,150 | 13,400 | 10,470 |
| Announcement Date | 3/21/23 | 3/21/23 | 3/18/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net sales 1 | 5,778 | 9,897 | 3,663 |
| EBITDA 1 | -1,194 | -3,748 | -5,703 |
| EBIT 1 | -2,006 | -4,926 | -6,911 |
| Operating Margin | -34.72% | -49.78% | -188.64% |
| Earnings before Tax (EBT) 1 | -1,875 | -4,545 | -6,459 |
| Net income 1 | -2,136 | -4,545 | -6,459 |
| Net margin | -36.96% | -45.92% | -176.31% |
| EPS 2 | -368.0 | -754.0 | -1,063 |
| Free Cash Flow | - | -4,058 | -3,356 |
| FCF margin | - | -41% | -91.61% |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 3/21/23 | 3/21/23 | 3/18/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q3 |
|---|---|
| Net sales 1 | 0.4836 |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income | - |
| Net margin | - |
| EPS | - |
| Dividend per Share | - |
| Announcement Date | 11/14/23 |
1KRW in Billions
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net Debt 1 | - | - | - |
| Net Cash position 1 | 22,075 | 16,735 | 11,491 |
| Leverage (Debt/EBITDA) | - | - | - |
| Free Cash Flow | - | -4,058 | -3,356 |
| ROE (net income / shareholders' equity) | - | -20.1% | -36.3% |
| ROA (Net income/ Total Assets) | - | -10.2% | -18.5% |
| Assets 1 | - | 44,398 | 35,006 |
| Book Value Per Share 2 | 4,070 | 3,439 | 2,432 |
| Cash Flow per Share 2 | 1,338 | 3,143 | 517.0 |
| Capex 1 | 377 | 384 | 87.5 |
| Capex / Sales | 6.53% | 3.88% | 2.39% |
| Announcement Date | 3/21/23 | 3/21/23 | 3/18/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -5.25% | 43.73M | |
| +20.72% | 3,374B | |
| +15.88% | 86.53B | |
| +66.98% | 63.85B | |
| -23.18% | 49.62B | |
| +39.09% | 48.96B | |
| -24.35% | 46.84B | |
| +77.46% | 41.28B | |
| -4.75% | 26.83B | |
| -10.08% | 26.31B |
- Stock Market
- Equities
- A189330 Stock
- Financials XIIlab Co.,Ltd
